These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
380 related items for PubMed ID: 20622270
21. [The treatment of paroxysmal supraventricular arrhythmias in IHD patients with a high risk of developing complications from the anti-arrhythmic therapy]. Andriushchenko OM, Olesin AI. Ter Arkh; 1996; 68(5):57-60. PubMed ID: 9082603 [Abstract] [Full Text] [Related]
22. [Role of a "bystander" concealed accessory pathway in the response to verapamil and flecainide treatment in a patient with nodal reentry tachycardia]. Matteucci C, Busi G. G Ital Cardiol; 1996 Apr; 26(4):419-25. PubMed ID: 8707026 [Abstract] [Full Text] [Related]
23. [Propafenon, a new antiarrhythmic agent for the treatment of ectopic and rapid cardiac arrhythmias (author's transl)]. Beck OA. Med Klin; 1975 Jan 17; 70(3-2):95-101. PubMed ID: 48183 [Abstract] [Full Text] [Related]
24. [Use of propafenone in emergency therapy]. Liguori A, Pellegrino G, Di Ieso N, Piatto A, Ruggiero P, Scarnera P, Guardascione A. Clin Ter; 1989 Dec 15; 131(5):307-14. PubMed ID: 2532584 [Abstract] [Full Text] [Related]
25. [Amiodarone-induced hyperthyroidism causing progression of arrhythmia]. Pintér A, Zámolyi K, Székely A, Préda I. Orv Hetil; 1994 Jul 10; 135(28):1535-8. PubMed ID: 8058296 [Abstract] [Full Text] [Related]
26. [Circulatory arrest after combined intravenous drugs for the treatment of orthodromic circular tachycardia of Wolff-Parkinson-White syndrome]. Gómez-Barrado JJ, García-Rubira JC, Turégano Albarrán S, Pavón García M, Hidalgo Urbano R, Montes Ramírez JM, Cruz Fernández JM. Rev Esp Cardiol; 1997 Sep 10; 50(9):662-6. PubMed ID: 9380937 [Abstract] [Full Text] [Related]
27. Electrophysiological effects and clinical efficacy of propafenone in children with recurrent paroxysmal supraventricular tachycardia. Musto B, D'Onofrio A, Cavallaro C, Musto A. Circulation; 1988 Oct 10; 78(4):863-9. PubMed ID: 3168194 [Abstract] [Full Text] [Related]
28. [Electrophysiological testing of multiple antiarrhythmic drugs in patients with paroxysmal supraventricular tachycardia after chronic oral administration]. Nishino T. Hokkaido Igaku Zasshi; 1989 Nov 10; 64(6):738-48. PubMed ID: 2606448 [Abstract] [Full Text] [Related]
29. [The anti-arrhythmia effect and hemodynamic effects of Bonnecor in intravenous administration]. Volkmann H, Kühnert H, Dannberg G, Küch N, Büttner A. Z Gesamte Inn Med; 1989 Dec 01; 44(23):707-11. PubMed ID: 2629366 [Abstract] [Full Text] [Related]
30. [An analysis of clinical characteristics and acute treatment of supraventricular tachycardia in children from a multicenter study]. Li XM, Ge HY, Liu XQ, Shi L, Guo BJ, Li MT, Jiang H, Zhang Y, Liu HJ, Zheng XC, Li AJ, Zhang YY. Zhonghua Er Ke Za Zhi; 2018 Jan 02; 56(1):13-18. PubMed ID: 29342991 [Abstract] [Full Text] [Related]
31. [Current treatment of supraventricular tachycardia: drug therapy]. Manz M, Lüderitz B. Z Gesamte Inn Med; 1993 Sep 02; 48(9):430-8. PubMed ID: 8212748 [Abstract] [Full Text] [Related]
33. Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias. A randomized, placebo-controlled, crossover trial in patients tolerating oral therapy. Pritchett EL, McCarthy EA, Wilkinson WE. Ann Intern Med; 1991 Apr 01; 114(7):539-44. PubMed ID: 2001087 [Abstract] [Full Text] [Related]
34. [The treatment of arrhythmias in infants and children using propafenone]. Dressler F, Grävinghoff L, Grütte E, Jüngst BK, Liersch R, Nomayo H, Puls I, Rautenburg HW, Schmaltz A, Schumacher G. Monatsschr Kinderheilkd; 1985 Mar 01; 133(3):154-7. PubMed ID: 4010670 [Abstract] [Full Text] [Related]
35. Adenosine-induced cardiopulmonary arrest in a patient with paroxysmal supraventricular tachycardia--a response. Jenkins NS, Knights M, Eickmann C, Payne M. Am J Emerg Med; 2010 May 01; 28(4):526; author reply 526-7. PubMed ID: 20466244 [No Abstract] [Full Text] [Related]
36. [Propafenone efficacy in preventing supraventricular tachycardia in childhood]. Bodegas A, Cabrera A, Sarrionaindía MJ, Idígoras G, Rumoroso JR, Pérez García P, Pastor E, Galdeano JM, Sota J, Barrenetxea JI. Rev Esp Cardiol; 1994 Feb 01; 47(2):86-91. PubMed ID: 8165353 [Abstract] [Full Text] [Related]
37. [Comparative study on the efficacy of disopyramide and propafenone in the prevention of the recurrence of ventricular tachycardia]. Palmieri M, Capucci A, Lombardi G, Naccarella F, Bomba E, Bracchetti D. G Ital Cardiol; 1984 May 01; 14(5):357-9. PubMed ID: 6468817 [Abstract] [Full Text] [Related]
38. [Efficacy of intravenous Acehytisine Hydrochloride versus propafenone on terminating paroxysmal supraventricular tachycardia: a double-blinded, randomized multi-center study]. Gao X, Zhu J, Yang YM, Li JD, Yang ZM, Liu JH, Acehytisine Hydrochloride Injection Phase II Clinic Trial Group Investigators. Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Feb 01; 35(2):151-4. PubMed ID: 17445412 [Abstract] [Full Text] [Related]
39. Long-term follow-up of patients with inducible supraventricular tachycardia treated with flecainide or propafenone: therapy guided by transesophageal electropharmacologic testing. Furlanello F, Guarnerio M, Inama G, Vergara G, Del Greco M, Bertoldi A, Dallago M. Am J Cardiol; 1992 Aug 20; 70(5):19A-25A. PubMed ID: 1509994 [Abstract] [Full Text] [Related]
40. [Usefulness of transesophageal electrophysiological study during the ergometric test in the evaluation of supraventricular paroxysmal tachycardia occurring during exertion]. Delise P, D'Este D, Bonso A, Allibardi P, Raviele A, Di Pede F, Piccolo E. G Ital Cardiol; 1989 Dec 20; 19(12):1094-104. PubMed ID: 2576799 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]